Results 41 to 50 of about 1,673 (95)

Immune Exhaustion in Chronic Infection and Cancer: Signaling Pathways and Therapeutic Interventions

MedComm, Volume 7, Issue 3, March 2026.
Immune exhaustion is a well‐established hallmark of both cancer and chronic infection. This review proposes a novel “infection–exhaustion–tumor axis” framework, wherein chronic pathogens (e.g., oncogenic viruses) evade immune surveillance by hijacking inflammatory signaling to drive immune cell exhaustion, thereby creating immunosuppressive niches ...
Yali Song, Yazhi Mo, Si Chen, Yuemei Chen, Chunying Zhang, Shanying Deng, Juan Liao, Yi He, Wei Wang, Weidong Zheng, Tingting Zeng   +10 more
wiley   +1 more source

Expanded strain coverage for a highly successful public health tool: Prophylactic 9-valent human papillomavirus vaccine

Human Vaccines & Immunotherapeutics, 2017
Human papillomavirus is considered the causative factor for cervical cancer, which accounts for approximately 5% of the global cancer burden and more than 600,000 new cases annually that are attributable to HPV infection worldwide.
Zhigang Zhang, Jun Zhang, Ningshao Xia, Qinjian Zhao   +3 more
doaj   +1 more source

High‐Risk HPV in Men: A Hidden Threat to Public Health?

Reviews in Medical Virology, Volume 36, Issue 2, March 2026.
ABSTRACT High‐risk human papillomavirus (HR‐HPV) infection is a leading cause of several cancers, including those of the genital and oropharyngeal regions. While public health efforts have largely focused on women due to its link to cervical cancer, HPV also poses significant risks to men, particularly in the oropharyngeal regions. HR‐HPV prevalence in
Keesha L. Coker, Ethan L. Morgan
wiley   +1 more source

Vaccine Name Framing, Relationship Status, and Fear: Examining Heterosexual Men's Intention to Vaccinate Against Human Papillomavirus Infection

World Medical &Health Policy, Volume 18, Issue 1, March 2026.
ABSTRACT Against the backdrop of calling for nonfemale‐oriented promotion of vaccination against human papillomavirus (HPV), this study explored three potential names—“HPV Vaccine,” “Cervical Cancer Vaccine,” and “Genital Warts Vaccine”—to promote vaccination against HPV infection among heterosexual men.
Timothy K. F. Fung, Judy Yuen‐man Siu, Ho Man Leung   +2 more
wiley   +1 more source

HPV vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 2, Page 377-385, February 2026.
HPV vaccination in women undergoing active surveillance for CIN2 does not offer a protective effect against progression to CIN3+. Women should be informed that vaccination is not a substitute for clinical follow‐up and should be encouraged to adhere to recommended surveillance and treatment protocols Abstract Introduction Human papillomavirus (HPV ...
Dina O. Eriksen, Louise Krog, Eva B. Ostenfeld, Pernille T. Jensen, Kathrine D. Lycke, Therese K. Grønborg, Nicolas Wentzensen, Megan A. Clarke, Anne Hammer   +8 more
wiley   +1 more source

Estado actual de la vacuna recombinante contra el virus del papiloma humano State of the art on human papillomavirus vaccine

Acta Médica Costarricense, 2008
La infección por el virus del papiloma humano (VPH) es una enfermedad de transmisión sexual común. Alrededor del mundo millones de personas están infectadas y el resto de la población en general tiene un riesgo de contraer la infección superior al 50 ...
Wendy Chan Acón, Lara Aguilar Morales, Carolina Soley, Adriano Arguedas Mohs   +3 more
doaj  

Distribution and role of high‐risk human papillomavirus genotypes in women with cervical intraepithelial neoplasia: A retrospective analysis from Wenzhou, southeast China

Cancer Medicine, 2018
To add the growing literature on baseline of high‐risk human papillomavirus (HR‐HPV) genotype distribution in cervical intraepithelial neoplasia (CIN) before the widespread using of HPV vaccines in Chinese mainland and to improve risk stratification of ...
Yuli Wang, Jisen Xue, Xinyue Dai, Lulu Chen, Junli Li, Yancheng Wu, Yan Hu   +6 more
doaj   +1 more source

Strategies for Developing Oral Vaccines for Human Papillomavirus (HPV) Induced Cancer using Nanoparticle mediated Delivery System

Journal of Pharmacy & Pharmaceutical Sciences, 2015
Human Papillomaviruses (HPV) are a diverse group of small non-enveloped DNA viruses. Some HPVs are classified as low-risk as they are very rarely associated with neoplasia or cancer in the general population, and cause lenient warts.
Mohammad Nasir Uddin, Samir A. Kouzi, Muhammad Delwar Hussain   +2 more
doaj   +1 more source

Acceptance of HPV Vaccination: A Systematic Review of Knowledge, Attitudes and Barriers Among Healthcare Practitioners in Low‐ and Middle‐Income Countries

BioMed Research International, Volume 2026, Issue 1, 2026.
Background Cervical cancer is one of the diseases that reflects global inequities. Vaccination against the human papillomavirus (HPV) is one of the main pillars of the World Health Organization (WHO) 2030 cervical cancer 90:70:90 elimination strategy. The role of healthcare practitioners in HPV vaccination acceptance cannot be overemphasized.
Nancy Innocentia Ebu Enyan, Mengying Zhang, Sebastian Ken-Amoah, Michelle King-Okoye, Joyce Agyeiwaa, Richard Sarfo-Walters, Dorothy Addo-Mensah, Patrick Kafui Akakpo, Dorcas Obiri-Yeboah, Lawrence Doi, Cassiano Gonçalves-de-Albuquerque   +10 more
wiley   +1 more source

Estado actual de la vacuna recombinante contra el virus del papiloma humano

Acta Médica Costarricense, 2008
La infección por el virus del papiloma humano (VPH) es una enfermedad de transmisión sexual común. Alrededor del mundo millones de personas están infectadas y el resto de la población en general tiene un riesgo de contraer la infección superior al 50 ...
Wendy Chan Acón, Lara Aguilar Morales, Carolina Soley, Adriano Arguedas Mohs   +3 more
doaj